July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
Quantitative fundus autofluorescence in macular and cone/cone-rod dystrophies
Author Affiliations & Notes
  • Martin Gliem
    Nuffield Laboratory of Ophthalmology, University of Oxford, Oxford, United Kingdom
    Oxford Eye Hospital, Oxford, United Kingdom
  • Johannes Birtel
    University Eye Hospital Bonn, Bonn, Germany
  • Philipp L. Mueller
    University Eye Hospital Bonn, Bonn, Germany
  • Frank G. Holz
    Oxford Eye Hospital, Oxford, United Kingdom
  • Peter Charbel Issa
    Nuffield Laboratory of Ophthalmology, University of Oxford, Oxford, United Kingdom
    Oxford Eye Hospital, Oxford, United Kingdom
  • Footnotes
    Commercial Relationships   Martin Gliem, Bayer (R), Carl Zeiss MediTec (F), CenterVue (F), Heidelberg Engineering (F), Heidelberg Engineering (R), Optos (F); Johannes Birtel, Carl Zeiss MediTec (F), CenterVue (F), Heidelberg Engineering (F), Optos (F); Philipp Mueller, Carl Zeiss MediTec (F), CenterVue (F), Heidelberg Engineering (F), Optos (F); Frank Holz, Acucela (C), Acucela (F), Acucela (R), Appelis (C), Appelis (R), Bayer (C), Bayer (F), Bayer (R), Bioeq/Formycon (F), Bioeq/Formycon (C), Boehringer-Ingelheim (C), CenterVue (F), Ellex (R), Geuder (C), Graybug Vision (C), Graybug Vision (R), Heidelberg Engineering (C), Heidelberg Engineering (F), Heidelberg Engineering (R), LinBioscience (C), LinBioscience (R), NightStarX (F), Roche/Genentech (C), Roche/Genentech (F), Roche/Genentech (R); Peter Charbel Issa, Heidelberg Engineering (F)
  • Footnotes
    Support  German Research Foundation Grant GL920-1/1
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 1333. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Martin Gliem, Johannes Birtel, Philipp L. Mueller, Frank G. Holz, Peter Charbel Issa; Quantitative fundus autofluorescence in macular and cone/cone-rod dystrophies. Invest. Ophthalmol. Vis. Sci. 2019;60(9):1333.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To quantitatively investigate lipofuscin-associated fundus autofluorescence in patients with macular and cone/cone-rod dystrophies (MD/CCRD).

Methods : 231 patients with MD/CCRD (aged 10-64 years) which had undergone genetic testing using a two-tier strategy consisting of Sanger-sequencing and next-generation sequencing were included in this prospective, monocenter, case-control study. Patients were examined using quantitative fundus AF (qAF) imaging with a modified confocal scanning laser ophthalmoscope equipped with an internal fluorescent reference (modified Spectralis HRA-OCT, Heidelberg Engineering). Mean qAF values of a circular ring centered to the fovea were measured and compared to 110 controls (aged 8-65) without any eye disease

Results : Genetic testing revealed causative mutations distributed across 22 different genes in 176 patients (76%). QAF-values were increased in 105 (45%), normal in 111 (48%) and reduced in 15 (7%) patients. Increased qAF-values were associated with mutations in ABCA4 (n=75; 71%), PRPH2 (n=9; 9%), CERKL (n=3; 3%), PROM1 (n=2; 2%), CRX (n=1; 1%) and CDHR1 (n=1; 1%). Reduced qAF-values were mainly found in patients with MERTK (n=3; 20%) and RDH5 (n=2; 13%) mutations. Normal qAF values were found associated with mutations in all genes except for MERTK and RDH5. In 14 patients with increased (13%), 35 with normal (32%) and 6 with reduced (40%) qAF values no causative mutation could be identified.

Conclusions : QAF imaging revealed characteristic qAF-levels in association with certain gene mutations but also in cases without detected causative mutations. These findings indicate that qAF may facilitate differential diagnostics of MD/CCRD and offer novel insights into the pathogenesis of MD/CCRD which might be of particular value for the assessment of future treatment options.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×